tVNS® E is a certified medical device indicated for the treatment of various neurological, psychiatric, and chronic conditions. These include:
- Anxiety
- Atrial Fibrillation
- Autism
- Cognitive Impairment
- Depression
- Epilepsy
- Irritable Bowel Syndrome (IBS)
- Inflammatory Bowel Disease (IBD) (including Crohn’s Disease & Ulcerative Colitis)
- Systemic Sclerosis
- Migraines
- Parkinson’s Disease
- Prader-Willi Syndrome (PWS)
- Sleep Disorders
- Tinnitus
Expected Benefits for Specific Conditions #
- Epilepsy – Clinical studies have shown tVNS® patients experienced a minimum 25% reduction in seizure frequency after a 20-week treatment period.
- Depression – Patients undergoing psychopharmacological and psychotherapy treatments alongside tVNS® have reported a reduction in the Hamilton Depression Rating Scale (HAMD) score by 2-3 points after 9 weeks of use.
- Prader-Willi Syndrome (PWS) – Clinical studies show that patients experienced a 50% reduction in temper outbursts after 12 months of treatment.
- Migraines – Studies show that tVNS® patients experienced a reduction of the frequency of days with migraine of 50% after a treatment period of 12 weeks.
Individual Responses May Vary #
The effects of tVNS® E depend on the condition being treated and individual responsiveness. Some patients experience improvements within weeks, while others may need several months to see changes. Consistency is key—daily use is required for optimal results.
If you have questions about how tVNS® E may help with your specific condition, please contact our team.